These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 23582016)
1. Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria. Rahul CN; Shiva Krishna K; Pawar AP; Bai M; Kumar V; Phadke S; Rajesh V J Biomol Struct Dyn; 2014 Apr; 32(4):580-90. PubMed ID: 23582016 [TBL] [Abstract][Full Text] [Related]
2. Plasmodium vivax: C-terminal diversity in the blood stage SERA genes from Indian field isolates. Rahul CN; Shiva Krishna K; Meera Bai N; Kumar V; Phadke S; Rajesh V Exp Parasitol; 2013 May; 134(1):82-91. PubMed ID: 23485360 [TBL] [Abstract][Full Text] [Related]
3. A knowledge-based approach for identification of drugs against vivapain-2 protein of Plasmodium vivax through pharmacophore-based virtual screening with comparative modelling. Yadav MK; Singh A; Swati D Appl Biochem Biotechnol; 2014 Aug; 173(8):2174-88. PubMed ID: 24970047 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of cysteine proteases of Plasmodium vivax as antimalarial drug targets: sequence analysis and sensitivity to cysteine protease inhibitors. Na BK; Kim TS; Rosenthal PJ; Lee JK; Kong Y Parasitol Res; 2004 Oct; 94(4):312-7. PubMed ID: 15372231 [TBL] [Abstract][Full Text] [Related]
5. Plasmodium vivax: N-terminal diversity in the blood stage SERA genes from Indian isolates. Rahul CN; Shiva Krishna K; Meera M; Phadke S; Rajesh V Blood Cells Mol Dis; 2015 Jun; 55(1):30-5. PubMed ID: 25976464 [TBL] [Abstract][Full Text] [Related]
6. Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions. Rayner JC; Huber CS; Feldman D; Ingravallo P; Galinski MR; Barnwell JW Infect Genet Evol; 2004 Dec; 4(4):309-19. PubMed ID: 15374528 [TBL] [Abstract][Full Text] [Related]
7. Sequence homology and structural analysis of plasmepsin 4 isolated from Indian Plasmodium vivax isolates. Rawat M; Vijay S; Gupta Y; Dixit R; Tiwari PK; Sharma A Infect Genet Evol; 2011 Jul; 11(5):924-33. PubMed ID: 21382523 [TBL] [Abstract][Full Text] [Related]
8. In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound. Bouillon A; Giganti D; Benedet C; Gorgette O; Pêtres S; Crublet E; Girard-Blanc C; Witkowski B; Ménard D; Nilges M; Mercereau-Puijalon O; Stoven V; Barale JC J Biol Chem; 2013 Jun; 288(25):18561-73. PubMed ID: 23653352 [TBL] [Abstract][Full Text] [Related]
9. High immunogenecity and erythrocyte-binding activity in the tryptophan-rich domain (TRD) of the 74-kDa Plasmodium vivax alanine-tryptophan-rich antigen (PvATRAg74). Alam MT; Bora H; Singh N; Sharma YD Vaccine; 2008 Jul; 26(31):3787-94. PubMed ID: 18579264 [TBL] [Abstract][Full Text] [Related]
10. Structural modeling identifies Plasmodium vivax 4-diphosphocytidyl-2C-methyl-d-erythritol kinase (IspE) as a plausible new antimalarial drug target. Kadian K; Vijay S; Gupta Y; Rawal R; Singh J; Anvikar A; Pande V; Sharma A Parasitol Int; 2018 Aug; 67(4):375-385. PubMed ID: 29550587 [TBL] [Abstract][Full Text] [Related]
11. Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax. Jalah R; Sarin R; Sud N; Alam MT; Parikh N; Das TK; Sharma YD Mol Biochem Parasitol; 2005 Aug; 142(2):158-69. PubMed ID: 15869815 [TBL] [Abstract][Full Text] [Related]
12. Identification and biochemical characterization of vivapains, cysteine proteases of the malaria parasite Plasmodium vivax. Na BK; Shenai BR; Sijwali PS; Choe Y; Pandey KC; Singh A; Craik CS; Rosenthal PJ Biochem J; 2004 Mar; 378(Pt 2):529-38. PubMed ID: 14629194 [TBL] [Abstract][Full Text] [Related]
13. High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Martinez P; Suarez CF; Gomez A; Cardenas PP; Guerrero JE; Patarroyo MA Infect Genet Evol; 2005 Oct; 5(4):354-61. PubMed ID: 16168942 [TBL] [Abstract][Full Text] [Related]
14. Genetic diversity of transmission blocking vaccine candidate (Pvs25 and Pvs28) antigen in Plasmodium vivax clinical isolates from Iran. Zakeri S; Razavi S; Djadid ND Acta Trop; 2009 Mar; 109(3):176-80. PubMed ID: 18950597 [TBL] [Abstract][Full Text] [Related]
15. Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5. Hodder AN; Drew DR; Epa VC; Delorenzi M; Bourgon R; Miller SK; Moritz RL; Frecklington DF; Simpson RJ; Speed TP; Pike RN; Crabb BS J Biol Chem; 2003 Nov; 278(48):48169-77. PubMed ID: 13679369 [TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax: genetic diversity of the apical membrane antigen-1 (AMA-1) in isolates from India. Rajesh V; Elamaran M; Vidya S; Gowrishankar M; Kochar D; Das A Exp Parasitol; 2007 Jul; 116(3):252-6. PubMed ID: 17336299 [TBL] [Abstract][Full Text] [Related]
18. Low genetic polymorphism of merozoite surface proteins 7 and 10 in Colombian Plasmodium vivax isolates. Garzón-Ospina D; Romero-Murillo L; Tobón LF; Patarroyo MA Infect Genet Evol; 2011 Mar; 11(2):528-31. PubMed ID: 21182986 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for the regulation of cysteine-protease activity by a new class of protease inhibitors in Plasmodium. Hansen G; Heitmann A; Witt T; Li H; Jiang H; Shen X; Heussler VT; Rennenberg A; Hilgenfeld R Structure; 2011 Jul; 19(7):919-29. PubMed ID: 21742259 [TBL] [Abstract][Full Text] [Related]
20. Crystal structure of Plasmodium vivax FK506-binding protein 25 reveals conformational changes responsible for its noncanonical activity. Rajan S; Austin D; Harikishore A; Nguyen QT; Baek K; Yoon HS Proteins; 2014 Jul; 82(7):1235-44. PubMed ID: 24302348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]